PROMIS NEUROSCIENCES INC COMMON SHARES (OTCMKTS:ARFXF)’s Trend Unknown, Especially After Increased Shorts

September 16, 2018 - By Victoria Pittman

ProMIS Neurosciences, Inc. (OTCMKTS:ARFXF) Logo

The stock of PROMIS NEUROSCIENCES INC COMMON SHARES (OTCMKTS:ARFXF) registered an increase of 20.53% in short interest. ARFXF’s total short interest was 250,700 shares in September as published by FINRA. Its up 20.53% from 208,000 shares, reported previously. With 170,300 shares average volume, it will take short sellers 2 days to cover their ARFXF’s short positions.

The stock decreased 4.55% or $0.01 during the last trading session, reaching $0.21. About 214,056 shares traded or 117.27% up from the average. ProMIS Neurosciences, Inc. (OTCMKTS:ARFXF) has 0.00% since September 16, 2017 and is . It has underperformed by 15.62% the S&P500.

ProMIS Neurosciences Inc., a development stage biotech company, discovers and develops precision medicine therapeutics for treatment of neurodegenerative diseases, primarily Alzheimer's disease and amyotrophic lateral sclerosis (ALS). The company has market cap of $54.12 million. The Company’s proprietary target discovery engine is based on the use of two complementary techniques. It currently has negative earnings. The firm applies its thermodynamic, computational discovery platform?ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.